Skip to headlines
clockwire Search
LIVE
Rising costs, shifting tastes push Osaka's takoyaki, okonomiyaki shops to the brink Nonprofit supporting research atop Mt. Fuji marks 20th anniversary Robot Dogs Carrying Rifles: New Weapons Deployed by Nayib Bukele in Haiti Japan flower farmer turns to exotic 'caviar of the forest' Seoul’s golden ginkgo trees have a stinky problem Prosecution miss? Pia Cayetano hits questioning on support for sports Student plot forced into solo landing following US ground stop Student plot forced into solo landing following US ground stop Semovi se reunirá con repartidores de aplicación tras ola de protestas Comment: Antoine Dupont leads Springboks on merry dance as Paris no longer South Africa’s happy place Hallan tres cuerpos sepultados en una vivienda de Ajacuba, Hidalgo; cateo derivó de una investigación por desaparición Cande Tinelli recordó su separación de Coti Sorokin: "Mucha soledad" ¿Parque o centro de eventos? Robert Pattinson dejaría de ser Batman tras la secuela dirigida por Matt Reeves Northern Ireland’s first cases of bluetongue this winter confirmed
Region All
✕
Quiet right now
My tabs

Drugs & pharma

6 stories in 24h · Health, Markets · Clear all filters

  1. The Mirror Drugs & pharma · United StatesThe MirrorGB 'Sudden sight loss' risk alert to people taking Wegovy or Mounjaro
  2. The Mirror Health · United StatesThe MirrorGB Grandad sues Ozempic maker Novo Nordisk claiming weight loss jab left him partially blind
  3. RTHK Drugs & pharma · ChinaRTHKHKState media Bitter pill for rivals as Eli Lilly scores China firstChina has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill…
  4. Drugs & pharma · JapanThe Korea HeraldKR Koreans eye day trips to Japan for cheaper MounjaroIn South Korean online forums devoted to Mounjaro, users were comparing flights to Japan and swapping tips on…
  5. Drugs & pharma · JapanVnExpress InternationalVN Koreans flock to Japan for weight-loss drug that costs a third of price at homeKorean travelers have booked every appointment at a Japanese telemedicine service through Nov. 19 as South Korea on…
  6. Markets · ChinaSouth China Morning PostCNSource has a paywall Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drugChina has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral…

1 story in other languages ·